title: Favorable responses to tocilizumab in two patients with cancer-related cachexia.
authors.forename: Haruhiko
authors.initials: H
authors.lastname: Hirata
authors.forename: Satoshi
authors.initials: S
authors.lastname: Tetsumoto
authors.forename: Takashi
authors.initials: T
authors.lastname: Kijima
authors.forename: Hiroshi
authors.initials: H
authors.lastname: Kida
authors.forename: Toru
authors.initials: T
authors.lastname: Kumagai
authors.forename: Ryo
authors.initials: R
authors.lastname: Takahashi
authors.forename: Yasushi
authors.initials: Y
authors.lastname: Otani
authors.forename: Koji
authors.initials: K
authors.lastname: Inoue
authors.forename: Hanako
authors.initials: H
authors.lastname: Kuhara
authors.forename: Kazuki
authors.initials: K
authors.lastname: Shimada
authors.forename: Izumi
authors.initials: I
authors.lastname: Nagatomo
authors.forename: Yoshito
authors.initials: Y
authors.lastname: Takeda
authors.forename: Sho
authors.initials: S
authors.lastname: Goya
authors.forename: Kazuyuki
authors.initials: K
authors.lastname: Yoshizaki
authors.forename: Ichiro
authors.initials: I
authors.lastname: Kawase
authors.forename: Isao
authors.initials: I
authors.lastname: Tachibana
authors.forename: Tadamitsu
authors.initials: T
authors.lastname: Kishimoto
authors.forename: Atsushi
authors.initials: A
authors.lastname: Kumanogoh
mesh_terms: D000368:Aged; D061067:Antibodies, Monoclonal, Humanized / Q000627:therapeutic use*; D002100:Cachexia / Q000175:diagnosis / Q000188:drug therapy* / Q000209:etiology*; D006801:Humans; D007275:Injections, Intravenous; D008297:Male; D008875:Middle Aged; D009369:Neoplasms / Q000150:complications* / Q000175:diagnosis / Q000188:drug therapy*
chemical_list: D061067:Antibodies, Monoclonal, Humanized; C502936:tocilizumab